Back to Executive Profile
Alpha

Alpha Profiles · Executive Profile

Christopher Frankenfield

Chief Financial and Operating Officer at Xilio Therapeutics, Inc. (NASDAQ: XLO)

https://registry.alpha.ac/people/christopher-frankenfield

CF

Generated 2026-11-06T00:55:13.317Z

Data as of 2026-11-06T00:55:13.023911+00:00

https://registry.alpha.ac/people/christopher-frankenfield